9 results
Stroke and bleeding risk stratification with the CHADS2-VASc and HAS-BLED schemas

#Diagnosis #Hematology #CHADS2 #CHADS2VASc #HASBLED #Comparison
Stroke and bleeding ... HAS-BLED schemas #Diagnosis ... #Hematology #CHADS2 ... #Score #Risk #Stroke ... #Bleed #Anticoagulation
CHA2DS2VASc vs HAS-BLED scores for stroke risk and bleed risk on anticoagulation

C	Congestive Heart Failure	1

H	Hypertension	1

A2	Age >75	2

D	Diabetes Mellitus	1

S2	Stroke,
for stroke risk ... 1 B Bleeding ... #Score #Risk #Stroke ... #AFib #Diagnosis ... #Hematology
HAS-BLED Score - Risk of Major Bleeding in 1 Year
Characteristics (1 point each)
 • Hypertension: Baseline
HAS-BLED Score - ... Risk of Major Bleeding ... #Risk #Bleeding ... #anticoagulation ... #diagnosis #stratification
Bleeding risk calculators - HAS-BLED (atrial fibrillation) and IMPROVE (VTE prophylaxis for inpatients)
Important notes:
 • No
Bleeding risk calculators ... #Risk #Scores # ... Calculators #Anticoagulation ... #Factors #Hematology ... #Diagnosis
HAS-BLED Score
 - Hypertension: Baseline SBP > 160mmHg
 - Renal disease: Cr > 2.6mg/dL, on HD,
HAS-BLED Score ... of antiplatelet meds ... #HASBLED #Risk ... #Score #Bleeding ... #Anticoagulation
HAS-BLED Score for Major Bleeding Risk of Anticoagulation in Atrial Fibrillation

A clinical mnemonic to estimate the
HAS-BLED Score for ... Risk of Anticoagulation ... point each) S - Stroke ... #Risk #Bleed #Anticoagulation ... Mnemonic #Acronym #Diagnosis
Hemophilia - Diagnosis and Management
Diagnosis:
 • Consistent bleeding history (unless screening for disease in family members
Avoid meds that ... ↑ bleeding risk ... Eric Strong @DrEricStrong ... - Strong Medicine ... Management #treatment #hematology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Anticoagulation ... - what is the bleeding ... • <6mo since stroke ... stratification #diagnosis
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... appropriate only for low risk ... patients with no CV risk ... Hydroxyurea + anticoagulation ... #hematology